Occudo Quantitative Strategies’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-24,003
| Closed | -$43.7K | – | 663 |
|
|
2024
Q3 | $43.7K | Buy |
24,003
+7,601
| +46% | +$13.8K | 0.01% | 666 |
|
|
2024
Q2 | $98.9K | Buy |
+16,402
| New | +$98.9K | 0.02% | 663 |
|
|
2022
Q4 | – | Sell |
-23,332
| Closed | -$223K | – | 936 |
|
|
2022
Q3 | $223K | Sell |
23,332
-49,617
| -68% | -$474K | 0.02% | 939 |
|
|
2022
Q2 | $590K | Buy |
72,949
+29,401
| +68% | +$238K | 0.05% | 560 |
|
|
2022
Q1 | $736K | Buy |
43,548
+11,439
| +36% | +$193K | 0.06% | 490 |
|
|
2021
Q4 | $690K | Buy |
+32,109
| New | +$690K | 0.06% | 491 |
|